Navigation Links
Mapping the genetic locus for triglycerides
Date:4/25/2008

Researchers have mapped out a region on human chromosome 1 that contributes to genetically elevated blood triglyceride levels, a major risk factor for heart disease.

Triglycerides (TG), the main form of dietary fat, continuously circulate in the blood, but if their concentration elevates the risk of atherosclerosis and subsequently heart disease increases. Circulating TG levels depend on many factors including diet, exercise, and smoking, but around 40% of the variation in the population is due to genetics.

To locate the genes contributing to increased TG levels, Qing Wang and colleagues scanned 714 Caucasians from 388 families with premature heart disease. They identified a novel region on chromosome 1, 1p31-32.

While this genetic locus does contain 375 known genes, the researchers highlighted three genes that are especially promising candidates: angiopoietin-like 3, which inhibits enzymes that break down fats; the receptor for the appetite hormone leptin; and sterol carrier protein 2, which helps convert cholesterol into bile acids.

The researchers also note that another recent study identified a single nucleotide polymorphism associated with elevated TG levels in the exact same region, solidifying this part of chromosome 1 as the TG region.


'/>"/>

Contact: Nick Zagorski
nzagorski@asbmb.org
301-634-7366
American Society for Biochemistry and Molecular Biology
Source:Eurekalert

Page: 1

Related biology news :

1. Prediction of RNA pseudoknots using heuristic modeling with mapping and sequential folding
2. Genetic sequencing of protein from T. rex bone confirms dinosaurs link to birds
3. American College of Medical Genetics makes genetic testing recommendations in new policy statement
4. Scientists clarify a mechanism of epigenetic inheritance
5. Genetic variant mimics effect of heart failure medications
6. Researchers discover critical detail of cellular defense against genetic mistakes
7. Concentrating on different aspects of pain leads to breakthrough in migraine genetics
8. Genetic Engineering & Biotechnology News reports on growing use of cell-based assays
9. Largest ever study of genetics of common disease just got bigger
10. A genetic cause for iron deficiency
11. Geneticist Francis Collins named first recipient of Inamori Ethics Prize at Case Western Reserve
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2017)... 2017 According to a new market research report ... Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region ... expected to grow from USD 14.30 Billion in 2017 to USD 31.75 ... ... MarketsandMarkets Logo ...
(Date:4/6/2017)... Forecasts by Product Type (EAC), ... End-Use (Transportation & Logistics, Government & Public Sector, Utilities ... Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), ... you looking for a definitive report on the $27.9bn ... ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... ... announced the three Winners and six Finalists of the 2017 Blavatnik Regional Awards ... the Blavatnik Family Foundation and administered by the New York Academy of Sciences ...
(Date:10/12/2017)... CA (PRWEB) , ... October ... ... (https://www.onramp.bio/ ) has launched Rosalind™, the first-ever genomics analysis platform specifically designed ... bioinformatics complexity. Named in honor of pioneering researcher Rosalind Franklin, who made ...
(Date:10/11/2017)... ... October 11, 2017 , ... Proscia Inc ... hosting a Webinar titled, “Pathology is going digital. Is your lab ready?” with ... adoption best practices and how Proscia improves lab economics and realizes an increase ...
(Date:10/11/2017)... Bay, Florida (PRWEB) , ... October 11, 2017 ... ... and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel ... (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the cell ...
Breaking Biology Technology: